Literature DB >> 14640352

Opioid treatment of chronic pain in patients with addiction.

Michael F Weaver1, Sidney H Schnoll.   

Abstract

Patients with a history of drug or alcohol addiction may present to physicians with pain complaints. The medical literature is weak on the treatment of pain with opioids in patients in recovery or active addiction. This is because inconsistent criteria were used to define addiction and the types of chronic pain. There are clear differences between physical dependence, tolerance, and addiction. Addiction is different from pseudoaddiction and must be determined by the patient's behavior after appropriate pain management. Long-acting opioids are often the medications of choice for moderate to severe pain control. Short-acting opioids can be used for breakthrough pain. There are many other medications that can enhance pain control as adjunctive analgesics. Drug-seeking behavior may be seen with either active addiction or pseudoaddiction, or as part of deviant behavior such as drug diversion. A way to distinguish between these conditions is by giving the patient appropriate pain medication and observing the pattern of behavior to determine which is causing the drug-seeking behavior. Safe prescribing of medications with abuse potential includes use of a medication agreement, setting goals with the patient, giving appropriate amounts of pain medication, monitoring with pill counts and drug screens, and careful documentation. Even patients with a history of addiction can benefit from opioid pain medications if monitored appropriately.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14640352     DOI: 10.1080/j354v16n03_02

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  11 in total

1.  Opioid misuse behaviors in adolescents and young adults in a hematology/oncology setting.

Authors:  Jennifer Harman Ehrentraut; Kathleen Danielle Kern; Sarah A Long; Angel Qi An; Lane G Faughnan; Doralina L Anghelescu
Journal:  J Pediatr Psychol       Date:  2014-09-14

Review 2.  At the intersection of alcohol use disorder and chronic pain.

Authors:  Nasim Maleki; Kelli Tahaney; Benjamin L Thompson; Marlene Oscar-Berman
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

Review 3.  Chronic opioid therapy in long-term cancer survivors.

Authors:  A Carmona-Bayonas; P Jiménez-Fonseca; E Castañón; A Ramchandani-Vaswani; R Sánchez-Bayona; A Custodio; D Calvo-Temprano; J A Virizuela
Journal:  Clin Transl Oncol       Date:  2016-07-21       Impact factor: 3.405

Review 4.  The role of the outpatient clinic nurse in monitoring opioid therapy.

Authors:  Pamela J Jennings
Journal:  Curr Pain Headache Rep       Date:  2004-08

Review 5.  Practical guide to the management of acute and chronic pain in the presence of drug tolerance for the healthcare practitioner.

Authors:  Nalini Vadivelu; Harman Singh-Gill; Gopal Kodumudi; Aaron Joshua Kaye; Richard D Urman; Alan David Kaye
Journal:  Ochsner J       Date:  2014

6.  Patient versus therapist alliance: whose perception matters?

Authors:  Angela R Bethea; Michelle C Acosta; Deborah L Haller
Journal:  J Subst Abuse Treat       Date:  2007-12-20

7.  Comparison of the efficacy of adding clonidine, chlorpromazine, promethazine, and midazolam to morphine pumps in postoperative pain control of addicted patients.

Authors:  Farnad Imani; Poupak Rahimzadeh; Seyyed Hamid Reza Faiz
Journal:  Anesth Pain Med       Date:  2011-07-01

Review 8.  Prescription Sedative Misuse and Abuse.

Authors:  Michael F Weaver
Journal:  Yale J Biol Med       Date:  2015-09-03

9.  Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Nicholas Dinubile; John Giordano; Eric R Braverman; Courtney E Truesdell; Debmalya Barh; Rajendra Badgaiyan
Journal:  J Addict Res Ther       Date:  2013-10-31

10.  Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?

Authors:  Igor Kissin
Journal:  J Pain Res       Date:  2013-07-04       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.